ENTITY
Genscript Biotech

Genscript Biotech (1548 HK)

50
Analysis
Health CareHong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
Refresh
30 Jul 2023 09:36

China Healthcare Weekly (Jul.28) - Starting Point of New Prosperity, MNCs Change Strategy, Genscript

AD+RNAi could be the start point of next round of biopharmaceutical prosperity. MNCs have begun to adjust their strategic business model in...

Logo
269 Views
Share
20 Jul 2022 09:03

2022H2 China Healthcare Investment Strategy and Top Picks

We analyze the investment strategy,top picks and logic in CXO,pharmaceuticals and medical device industry.As a “defensive sector”,China healthcare...

Logo
339 Views
Share
bullishLi Auto
14 Nov 2023 13:31

Quiddity Leaderboard for Hang Seng Index Dec 23: High Conviction Names Have Decent Momentum Vs HSI

The Hang Seng Index changes for Dec 23 will be published after the close on Friday 17th November 2023. In this insight, you can see Quiddity's...

Share
14 Nov 2023 08:55

China’s China Weight Loss Drug Market Update – the Negatives and the True Colors

Some popular companies are favored by capital on the back of enthusiasm for weight loss drugs, but sometimes it's just "conceptual hype". We need...

Logo
327 Views
Share
bearishSunho Biologics
24 Aug 2023 08:55

Pre-IPO Sunho Biologics (SHB HK) - High Valuations Can Be Hard to Come By

Sunho does not have any drugs at NDA/BLA stage or commercialized products. Its outlook is highly uncertain due to challenging clinical trials...

Logo
330 Views
Share
x